Determining the Role of Atrazine and Atrazine-Induced Estrogen in Increasing CD4+
确定莠去津和莠去津诱导的雌激素在增加 CD4 中的作用
基本信息
- 批准号:8429920
- 负责人:
- 金额:$ 7.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-12-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAffectAgonistAgricultureAmericanAntibodiesAntigensAromataseAtrazineAutoimmune ProcessBindingCD4 Positive T LymphocytesCYP19A1 geneCell CountCell MaturationCellsCommunicable DiseasesCytokine ActivationCytolysisDendritic CellsEndocrine DisruptorsEnvironmental PollutionEstrogen AntagonistsEstrogensExperimental Autoimmune EncephalomyelitisExposure toFrequenciesGenerationsHealthHelper-Inducer T-LymphocyteHerbicidesImmuneImmune responseImmune systemImmunosuppressionIn VitroIndividualInfectionInflammatoryLeadLinkMale InfertilityMalignant NeoplasmsMediatingMitogensModelingMusNaturePhenotypePredispositionProductionRegulatory T-LymphocyteReportingReproductionResearchRiskRoleSeasonsSelf ToleranceSeverity of illnessShapesSignal TransductionSystemT-Cell ActivationT-LymphocyteTestingTransgenic MiceTransgenic OrganismsUnited StatesWaterWorkantibody inhibitorantigen challengecytokinedrinking waterfightingground waterimmune functionin vivointerestmalemicrobialneurotoxicitypathogenpublic health relevancereceptorreproductiveresearch study
项目摘要
DESCRIPTION (provided by applicant): Atrazine is one of the most widely used herbicide in the United States. As a result of agricultural runoff after crop applications, it is the most commo ground water contaminant in the US (://water.usgs.gov/nawqa/). Atrazine is classified as an Endocrine-Disrupting Compound due its induction of CYP19 (aromatase), whose catalytic activity leads to increased estrogen production. While a significant amount of research has been done looking into the potential health risks associated with atrazine exposure, most have focused on reproduction abnormalities related to elevated estrogen. A small number of studies have examined the effect of atrazine on the mammalian immune system, but the effects on the immune system remain largely unknown. None of the previous studies have focused on the activation and functions of a critical subset of immune cells, the CD4+ T helper cells. These cells help shape the protective immune response to pathogens and cancer as well as maintaining tolerance of self. Perturbations of CD4+ T cell numbers or effector activity can have dire consequences for the health of the individual. For example, an increase in regulatory T cells (Treg), can lead to immune suppression and resulting in increased susceptibility to infection or cancer. In preliminary in vitro studies, it was observed that atrazine exposure significantly inhibits the proliferation, activation and cytokine production by conventional T cells. Further, there is a significant increase in the frequency of Foxp3+ Treg in atrazine-exposed cells. In this proposal we will examine the mechanism of atrazine-mediated inhibition of CD4+ T cells. The hypothesis of this proposal is that atrazine increases estrogen levels which suppresses CD4+ T cell activation by both directly inhibiting these cells and by inducing a significant increase of Treg cells. It will be tested using 2 specific aims: In the first aim, the mechanism of atrazine-induced Treg frequency will be examined in vitro and in vivo. Using TCR transgenic T cells from Foxp3gfp+ OT-II mice, we will determine whether atrazine is inducing expansion of nTreg or conversion of conventional T cells to induced Treg (iTreg) cells. We will also examine the direct effects of atrazine exposure on the phenotype of conventional T cells in the absence of Treg. In the second aim, using a combination of pharmacological inhibitors and antibody blockade, the role of atrazine-mediated estrogen production on the Treg increase will be examined.
描述(由申请人提供):阿特拉津是美国使用最广泛的除草剂之一。作为作物施用后农业径流的结果,它是美国最常见的地下水污染物(://water.usgs.gov/nawqa/)。阿特拉津因其诱导CYP19(芳香化酶)而被归类为内分泌干扰化合物,其催化活性导致雌激素产生增加。虽然已经有大量的研究调查了与阿特拉津接触有关的潜在健康风险,但大多数研究都集中在与雌激素升高有关的生殖异常上。少数研究调查了阿特拉津对哺乳动物免疫系统的影响,但对免疫系统的影响在很大程度上仍然未知。之前的研究都没有关注免疫细胞的一个关键亚群——CD4+ T辅助细胞的激活和功能。这些细胞有助于形成对病原体和癌症的保护性免疫反应,以及维持自我耐受性。CD4+ T细胞数量或效应活性的扰动可能对个体的健康产生可怕的后果。例如,调节性T细胞(Treg)的增加可导致免疫抑制并导致对感染或癌症的易感性增加。在初步的体外研究中,观察到阿特拉津暴露显著抑制常规T细胞的增殖、活化和细胞因子的产生。此外,暴露于阿特拉津的细胞中Foxp3+ Treg的频率显著增加。在这个提议中,我们将研究阿特拉津介导的CD4+ T细胞抑制的机制。该建议的假设是,阿特拉津增加雌激素水平,通过直接抑制CD4+ T细胞和诱导Treg细胞显著增加来抑制CD4+ T细胞的激活。试验将采用两个特定目的:第一个目的是在体外和体内研究阿特拉津诱导Treg频率的机制。利用Foxp3gfp+ OT-II小鼠的TCR转基因T细胞,我们将确定阿特拉津是诱导nTreg扩增还是诱导常规T细胞向诱导Treg (iTreg)细胞转化。我们还将研究在Treg缺失的情况下,阿特拉津暴露对常规T细胞表型的直接影响。在第二个目标中,使用药物抑制剂和抗体阻断的组合,阿特拉津介导的雌激素产生对Treg增加的作用将被检查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT Allen WETZEL其他文献
SCOTT Allen WETZEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT Allen WETZEL', 18)}}的其他基金
Determining the role of trogocytosis-mediated signaling on CD4 T cell phenotype and effector functions
确定 trogocytosis 介导的信号传导对 CD4 T 细胞表型和效应功能的作用
- 批准号:
9228931 - 财政年份:2016
- 资助金额:
$ 7.08万 - 项目类别:
Determining the role of trogocytosis-mediated signaling on CD4 T cell phenotype and effector functions
确定 trogocytosis 介导的信号传导对 CD4 T 细胞表型和效应功能的作用
- 批准号:
9110454 - 财政年份:2016
- 资助金额:
$ 7.08万 - 项目类别:
Determining the Role of Atrazine and Atrazine-Induced Estrogen in Increasing CD4+
确定莠去津和莠去津诱导的雌激素在增加 CD4 中的作用
- 批准号:
8588931 - 财政年份:2012
- 资助金额:
$ 7.08万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 7.08万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 7.08万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 7.08万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 7.08万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 7.08万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 7.08万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 7.08万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 7.08万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 7.08万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 7.08万 - 项目类别: